Marchex(MCHX)

Search documents
Marchex(MCHX) - 2021 Q2 - Quarterly Report
2021-08-12 20:09
UNITED STATES SECURITIES AND EXCHANGE COMMISSION ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-50658 Marchex, Inc. (Exact name of Registrant as specified in its charter) WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR Delaware 35-2194038 (State or other jurisdiction of ...
Marchex(MCHX) - 2021 Q2 - Earnings Call Transcript
2021-08-08 16:23
Marchex, Inc. (NASDAQ:MCHX) Q2 2021 Earnings Conference Call August 4, 2021 5:00 PM ET Company Participants Trevor Caldwell ??? Senior Vice President of Investor Relations and Strategic Initiatives Michael Arends ??? Chief Executive Officer Russell Horowitz ??? Executive Chairman Leila Kirske ??? Chief Financial Officer Conference Call Participants Austin Vetterick ??? ROTH Capital Partners Operator Good afternoon. Thank you for attending the Marchex???s Second Quarter 2021 Earnings Call. [Operator Instruct ...
Marchex(MCHX) - 2021 Q1 - Earnings Call Transcript
2021-05-14 03:04
Marchex, Inc. (NASDAQ:MCHX) Q1 2021 Earnings Conference Call May 13, 2021 5:00 PM ET Company Participants Trevor Caldwell - SVP IR Michael Arends - Co-CEO Russell Horowitz - Co-CEO Leila Kirske - CFO Conference Call Participants Operator Good afternoon. My name is Celine. And I will be your conference operator today. At this time, I would like to welcome everyone to the Marchex First Quarter 2021 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speaker ...
Marchex(MCHX) - 2021 Q1 - Quarterly Report
2021-05-13 20:23
UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR WASHINGTON, D.C. 20549 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FORM 10-Q For the transition period from to . (Mark One) Commission File Number 000-50658 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 Marchex, Inc. (Exact name of Registrant as specified in its charter) Delaware 35-2194038 (State or other jurisdiction of ...
Marchex(MCHX) - 2020 Q4 - Annual Report
2021-03-31 19:40
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 000-50658 Marchex, Inc. | (Exact name of Registrant as specified in its Charter) | | --- | | Delaware 35-2194038 | | | --- | --- | | (Sta ...
Marchex(MCHX) - 2020 Q4 - Earnings Call Transcript
2021-03-03 01:58
Marchex, Inc. (NASDAQ:MCHX) Q4 2020 Earnings Conference Call March 2, 2021 5:00 PM ET Company Participants Trevor Caldwell - Senior Vice President-Strategic Initiatives & Investor Relations Michael Arends - Co-Chief Executive Officer & Chief Financial Officer Russell Horowitz - Executive Chairman & Co-Chief Executive Officer Conference Call Participants Mike Latimore - Northland Securities Operator Ladies and gentlemen, thank you for standing by and welcome to the Marchex Fourth Quarter 2020 Earnings Call. ...
Marchex(MCHX) - 2020 Q3 - Quarterly Report
2020-11-05 21:08
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-50658 Marchex, Inc. (Exact name of Registrant as specified in its charter) Delaware 35-2194038 (State or other jurisdictio ...
Marchex(MCHX) - 2020 Q3 - Earnings Call Transcript
2020-11-05 01:28
Financial Data and Key Metrics Changes - For Q3 2020, revenues were $26.5 million, reflecting the impact of the COVID-19 pandemic, with call volumes partially recovering in the summer [21][10] - Adjusted operating loss before amortization for the third quarter was $1.7 million, and adjusted EBITDA was a loss of $1.3 million [32] - Net loss applicable to common stockholders was $3.7 million for Q3 2020, or $0.08 per diluted share, compared to a net loss of $1.2 million or $0.03 per diluted share for Q3 2019 [32] Business Line Data and Key Metrics Changes - Core analytics and solutions revenue was $13.6 million for the quarter, with an adjusted figure of approximately $12.9 million when excluding a disrupted auto customer [26] - Marketplace and local leads platform revenues were down slightly on a sequential and year-over-year basis, primarily due to the decline from the legacy local leads platform [28] Market Data and Key Metrics Changes - The speech analytics market is expected to grow to more than $2 billion in the next two years, indicating a significant opportunity for the company [8] - There were increases in appointment trends in verticals like home services, dental, and auto, which historically peak in summer [24] Company Strategy and Development Direction - The company has transitioned to focus on conversational intelligence and sales engagement, separating its media assets for a clearer strategic direction [6] - Marchex aims to capitalize on the emerging multibillion-dollar market by delivering customizable, visual analytics to help businesses understand customer engagement [9] Management's Comments on Operating Environment and Future Outlook - Management noted that despite the fluid economic conditions due to COVID-19, there are signs of recovery in certain verticals and increasing willingness from customers to plan for future opportunities [10] - The company anticipates organic double-digit annual revenue growth for core analytics and solutions as the business environment normalizes in 2021 [37] Other Important Information - The company ended Q3 with approximately $39 million in cash on hand, net of current debt obligations, which was reduced to approximately $28 million after a tender offer [33] - The company has made significant investments in research and development, totaling over $100 million, and holds more than 40 patents [17] Q&A Session Summary Question: Inquiry about the Sonar acquisition and its integration timeline - Management indicated that the acquisition of Sonar has accelerated product development, with integrated voice and text solutions expected to be delivered to market shortly [45] Question: Clarification on the assumptions for achieving double-digit organic growth - Management acknowledged uncertainty regarding the full impact of COVID but expressed optimism about progress in 2021, even if the pandemic is not completely behind [48][49] Question: Call volume trends from June to October - Management reported that call volumes were lowest in April, with recovery seen in May and June, but seasonal declines were noted in September and October [53] Question: Adjustments made for customer pricing during the pandemic - Management confirmed that they provided pricing breaks and modified packages during the pandemic, but conditions have largely returned to normal [56]
Marchex(MCHX) - 2020 Q2 - Quarterly Report
2020-08-10 20:05
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-50658 Marchex, Inc. (Exact name of Registrant as specified in its charter) Delaware 35-2194038 (State or other jurisdiction of ...
Marchex(MCHX) - 2020 Q1 - Quarterly Report
2020-05-19 20:54
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-50658 Marchex, Inc. (Exact name of Registrant as specified in its charter) Delaware 35-2194038 (State or other jurisdiction of ...